[go: up one dir, main page]

ES2102971B1 - Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. - Google Patents

Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.

Info

Publication number
ES2102971B1
ES2102971B1 ES09600168A ES9600168A ES2102971B1 ES 2102971 B1 ES2102971 B1 ES 2102971B1 ES 09600168 A ES09600168 A ES 09600168A ES 9600168 A ES9600168 A ES 9600168A ES 2102971 B1 ES2102971 B1 ES 2102971B1
Authority
ES
Spain
Prior art keywords
prrs
respiratory
vaccines
new
procedures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09600168A
Other languages
English (en)
Other versions
ES2102971A1 (es
Inventor
Burch Reina Alemany
Maso Enric Espuna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Hipra SA
Original Assignee
Laboratorios Hipra SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Hipra SA filed Critical Laboratorios Hipra SA
Priority to ES09600168A priority Critical patent/ES2102971B1/es
Priority to UA97105158A priority patent/UA68326C2/uk
Priority to BR9604888A priority patent/BR9604888A/pt
Priority to CZ19973377A priority patent/CZ286766B6/cs
Priority to PCT/ES1996/000234 priority patent/WO1997027288A1/es
Priority to HU9801124A priority patent/HUP9801124A3/hu
Priority to CA002216436A priority patent/CA2216436A1/en
Priority to CN96194133A priority patent/CN1185806A/zh
Priority to US08/930,330 priority patent/US6001370A/en
Priority to PL96322455A priority patent/PL185841B1/pl
Priority to EP96940665A priority patent/EP0835929A1/en
Priority to JP9526571A priority patent/JP3068204B2/ja
Priority to KR1019970706672A priority patent/KR19980703268A/ko
Publication of ES2102971A1 publication Critical patent/ES2102971A1/es
Priority to MXPA/A/1997/007302A priority patent/MXPA97007302A/es
Application granted granted Critical
Publication of ES2102971B1 publication Critical patent/ES2102971B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/815—Viral vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE UNA NUEVA CEPA ATENUADA (CNMC INSTITUT PASTEUR I-1642) DEL VIRUS CAUSANTE DE LA ENFERMEDAD DEL GANADO PORCINO CONOCIDA COMO SINDROME RESPIRATORIO Y REPRODUCTIVO PORCINO (PRRS), ASI COMO UN PROCEDIMIENTO DE ATENUACION Y REPLICACION DE LA MISMA POR MEDIO DEL EMPLEO DE UN NUEVO CLON OBTENIDO A PARTIR DE CEDULAS DE RIÑON DE MONO MA-104 (CNMC INSTITUT PASTEUR I-1643). DEBIDO A SU INOCUIDAD PARA LOS SUIDOS Y A SU ELEVADA ACTIVIDAD INMUNOGENICA, LA MENCIONADA NUEVA CEPA ATENUADA PERMITE OBTENER VACUNAS Y MEDIOS DE DIAGNOSTICO QUE POSIBILITAN UN DIAGNOSTICO PRECOZ DEL PRRS Y UN EFICAZ TRATAMIENTO PREVENTIVO DE DICHA ENFERMEDAD.
ES09600168A 1996-01-25 1996-01-25 Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. Expired - Fee Related ES2102971B1 (es)

Priority Applications (14)

Application Number Priority Date Filing Date Title
ES09600168A ES2102971B1 (es) 1996-01-25 1996-01-25 Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
UA97105158A UA68326C2 (en) 1996-01-25 1996-04-12 An attenuated strain of the virus causing the porcine reproductive and respiratory syndrom (prrs), a vaccine for porcine protection from prrs, a method for preparation of active vaccine against prrs
JP9526571A JP3068204B2 (ja) 1996-01-25 1996-12-04 ブタの生殖・呼吸症候群（ｐｒｒｓ）を惹起するウイルスの新規弱毒化株、それに由来するワクチンおよび診断キットならびにそれらの取得方法。
PCT/ES1996/000234 WO1997027288A1 (es) 1996-01-25 1996-12-04 Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion
HU9801124A HUP9801124A3 (en) 1996-01-25 1996-12-04 New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process
CA002216436A CA2216436A1 (en) 1996-01-25 1996-12-04 New attenuated strain of the virus causing the porcine reproductive and respiratory syndrome (prrs), vaccines and diagnostic kits derived from the same, and procedures for the obtaining of the same
CN96194133A CN1185806A (zh) 1996-01-25 1996-12-04 诱发猪生殖和呼吸综合征(prrs)的病毒的新的减毒株,由其产生的疫苗和诊断试剂盒及其制备方法
US08/930,330 US6001370A (en) 1996-01-25 1996-12-04 Attenuated strain of the virus causing the porcine reproductive respiratory syndrome (PRRS), and vaccines
BR9604888A BR9604888A (pt) 1996-01-25 1996-12-04 Nova linhagem atenuada do vírus causador da síndrome suína reprodutiva e respiratória (prrs) vacinas clone celularderivado da linha estável de células renais de macaco ma-104 kits de diagnóstico obteníveis com a mesma procedimentos para a sua obtenção e uso da mesma
EP96940665A EP0835929A1 (en) 1996-01-25 1996-12-04 New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process
CZ19973377A CZ286766B6 (en) 1996-01-25 1996-12-04 Attenuated virus strain, process of its preparation, vaccine, process of its preparation, cellular clone and use of the attenuated strain
KR1019970706672A KR19980703268A (ko) 1996-01-25 1996-12-04 돼지의 생식 및 호흡 장애 증후군(prrs)을 유발하는 바이러스의 신종 약독화 균주와, 그 균주로써 얻을 수 있는 백신 및 진단수단과, 제조공정
PL96322455A PL185841B1 (pl) 1996-01-25 1996-12-04 Nowy atenuowany szczep wirusa powodującego zespółNowy atenuowany szczep wirusa powodującego zespółrozrodczy i oddechowy świń (PRRS), szczepionki i zrozrodczy i oddechowy świń (PRRS), szczepionki i zestawy diagnostyczne otrzymane z tego wirusa orazestawy diagnostyczne otrzymane z tego wirusa orazsposoby ich otrzymywaniasposoby ich otrzymywania
MXPA/A/1997/007302A MXPA97007302A (es) 1996-01-25 1997-09-24 Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09600168A ES2102971B1 (es) 1996-01-25 1996-01-25 Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.

Publications (2)

Publication Number Publication Date
ES2102971A1 ES2102971A1 (es) 1997-08-01
ES2102971B1 true ES2102971B1 (es) 1998-03-01

Family

ID=8293550

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09600168A Expired - Fee Related ES2102971B1 (es) 1996-01-25 1996-01-25 Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.

Country Status (13)

Country Link
US (1) US6001370A (es)
EP (1) EP0835929A1 (es)
JP (1) JP3068204B2 (es)
KR (1) KR19980703268A (es)
CN (1) CN1185806A (es)
BR (1) BR9604888A (es)
CA (1) CA2216436A1 (es)
CZ (1) CZ286766B6 (es)
ES (1) ES2102971B1 (es)
HU (1) HUP9801124A3 (es)
PL (1) PL185841B1 (es)
UA (1) UA68326C2 (es)
WO (1) WO1997027288A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587780B2 (en) * 1991-06-06 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
US6773908B1 (en) 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6380376B1 (en) * 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
US6592873B1 (en) 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US20040224327A1 (en) * 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
ES2323445T3 (es) 1999-02-10 2009-07-16 Serono Genetics Institute S.A. Marcadores polimorficos del gen lsr.
JP3961222B2 (ja) * 1999-03-08 2007-08-22 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー Ｐｒｒｓｖワクチン
MXPA01010681A (es) * 1999-04-22 2003-08-20 Us Agriculture Vacuna de sindrome respiratorio y reproductiva porcina a base de ja-142 aislado.
SG83740A1 (en) * 1999-08-10 2001-10-16 Inst Of Molecular Agrobiology An attenuated porcine reproductive and respiratory syndrome virus strain and methods of use
US7338787B2 (en) 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
EP1156111A1 (en) * 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Chimeric arterivirus-like particles
BRPI0116018B1 (pt) 2000-12-07 2018-02-27 Syngenta Limited Polinucleotídeo, métodos para fornecer uma planta que seja tolerante aos herbicidas inibidores da hppd e para controlar seletivamente ervas daninhas em um local compreendendo plantas de safra e ervas daninhas
AU2002309486A1 (en) * 2001-01-30 2002-10-15 The Lauridsen Group, Incorporated Methods and compositions for modulating the immune system of animals
KR20050040172A (ko) * 2003-10-27 2005-05-03 주식회사 중앙백신연구소 돼지 생식기호흡기 증후군 바이러스 불활화 백신의 제조방법
KR20070028547A (ko) 2004-06-18 2007-03-12 리전츠 오브 더 유니버스티 오브 미네소타 바이러스에 감염되고 백신접종된 생물의 동정
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
AU2005306781B2 (en) * 2004-11-19 2011-12-22 Intervet International B.V. Porcine reproductive and respiratory syndrome virus strains and compositions
SI1904631T1 (sl) 2005-06-24 2012-09-28 Univ Minnesota Virusi PRRS, infekciozni kloni, njihovi mutanti in postopki uporabe
DK1968630T5 (en) 2005-12-29 2018-08-13 Boehringer Ingelheim Vetmedica Inc MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS.
CN100523177C (zh) * 2007-01-09 2009-08-05 中国农业科学院哈尔滨兽医研究所 猪繁殖与呼吸综合症病毒弱毒疫苗株及其应用
BRPI0917887A2 (pt) * 2008-08-25 2019-09-03 Boehringer Ingelheim Vetmedica Inc vacina contra síndrome reprodutiva e respiratória suína altamente patogênica (hp pprs)
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
MY183980A (en) 2011-02-17 2021-03-17 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
DK2675475T3 (en) 2011-02-17 2015-09-14 Boehringer Ingelheim Vetmed NEW EUROPEAN PRRSV TRIAL
KR101281361B1 (ko) * 2011-07-18 2013-07-02 서울대학교산학협력단 북미형 돼지 생식기 호흡기 증후군 바이러스 예방 백신 조성물 및 이를 포함하는 혼합백신 조성물
US9315781B2 (en) 2011-07-29 2016-04-19 Boehringer Ingelheim Vetmedica Gmbh Infectious CDNA clone of european PRRS virus and uses thereof
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
KR102012109B1 (ko) * 2012-05-17 2019-08-19 조에티스 엘엘씨 이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종
CA2892948C (en) 2012-12-07 2022-09-20 The Board Of Trustees Of The University Of Illinois Porcine reproductive and respiratory syndrome virus compositions and uses thereof
CN105073130A (zh) 2013-03-15 2015-11-18 勃林格殷格翰动物保健公司 猪生殖与呼吸综合征病毒、组合物、疫苗及使用方法
ES2729838T3 (es) 2013-12-20 2019-11-06 Boehringer Ingelheim Vetmedica Gmbh Variante del virus del PRRS, clon de ADNc del virus del PRRS europeo y usos del mismo
JP6941171B2 (ja) 2016-11-03 2021-09-29 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーＢｏｅｈｒｉｎｇｅｒ Ｉｎｇｅｌｈｅｉｍ Ｖｅｔｍｅｄｉｃａ ＧｍｂＨ ブタパルボウイルスおよびブタ繁殖呼吸障害症候群ウイルスに対するワクチン、ならびにこれらを作製する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587780B2 (en) * 1991-06-06 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
MX9204885A (es) * 1991-08-26 1994-05-31 Boehringer Animal Health Inc Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos.
EP0601062B2 (en) * 1991-08-26 2000-12-13 Regents Of The University Of Minnesota Sirs vaccine and diagnosis method
CA2121241C (en) * 1991-10-14 2007-12-04 Nicolaas Visser Porcine reproductive respiratory syndrome vaccine and diagnostic
EP0683816B1 (en) * 1993-02-08 2000-11-02 Bayer Corporation Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
EP0676467B1 (en) * 1994-04-11 2001-10-04 Akzo Nobel N.V. European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)

Also Published As

Publication number Publication date
CN1185806A (zh) 1998-06-24
CA2216436A1 (en) 1997-07-31
HUP9801124A2 (hu) 1998-08-28
JPH10507372A (ja) 1998-07-21
WO1997027288A1 (es) 1997-07-31
US6001370A (en) 1999-12-14
HUP9801124A3 (en) 1999-09-28
CZ337797A3 (cs) 1998-03-18
MX9707302A (es) 1998-06-30
KR19980703268A (ko) 1998-10-15
EP0835929A1 (en) 1998-04-15
PL185841B1 (pl) 2003-08-29
PL322455A1 (en) 1998-02-02
JP3068204B2 (ja) 2000-07-24
ES2102971A1 (es) 1997-08-01
UA68326C2 (en) 2004-08-16
BR9604888A (pt) 1998-12-15
CZ286766B6 (en) 2000-06-14

Similar Documents

Publication Publication Date Title
ES2102971B1 (es) Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
ATE131067T1 (de) Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei schweinen (prrs) und diagnose.
ES2089316T3 (es) Agente viral asociado con la enfermedad porcina misteriosa (mystery swine desease).
NO20052306L (no) Dispergerbare farmasoytiske blandinger.
DK1263729T3 (da) Cykliske azaforbindelser til anvendelse til behandling af serotoninrealterede sygdomme
ES512044A0 (es) "un aparato medico, particularmente para realizar un examen isocentrico, por ejemplo, de vasos sanguineos".
ES2064329T3 (es) Compuestos hexaciclicos.
DK1202725T3 (da) Metode til behandling af symptomer på hormonal variation, herunder hedeture
HUP9900940A2 (hu) Helicobacter ellen ható nizin és glicerin-monolaurát kombináció
RU2415682C1 (ru) Дренирующее устройство для плевральной полости
BR0317544A (pt) Uso de uma composição que compreende vlps de hpv 16 e hpv 18, e, métodos para induzir uma resposta imune contra um ou mais do grupo de tipos de hpv oncogênicos, para prevenir infecção e/ou doença causada por um ou mais do grupo de tipos de hpv oncogênicos, para prevenir a infecção de uma população de pacientes por um ou mais tipos de hpv, uso de uma mistura de vlps de hpv 16 e hpv18, e, composição de vacina
CN106798612A (zh) 一种医用耳道清洗器
UY27434A1 (es) Clon del virus de la diarrea viral infecciosa bovina
BR112021026812A2 (pt) Ligantes de antígeno de membrana específico da próstata (psma) e usos dos mesmos
ES2168324T3 (es) Benzoilguanidinas sustituidas con heterociclos-n-oxidos, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico, asi como medicamento que las contiene.
MX2022013080A (es) Una combinacion de vacunas para el tratamiento profilactico de un cerdo.
CN117398396B (zh) 川楝素在制备防治猪繁殖与呼吸综合征药物中的用途
Jordan et al. Modified live PRRS vaccination provides heterologous protection against virulent 1-18-2 challenge
CN109821080A (zh) 一种神经外科临床中积液处理装置
Jeppsson et al. Audiological aspects of acute otitis media
CN103170023A (zh) 一种艾滋病治疗仪及制造方法
Atrash et al. Can Alka-White Mouthwash Reduce the Viral Load of COVID-19 in the Oropharynx?
KIM et al. Efficacy and safety of Ustekinumab in Korean patients with moderate-to-severe psoriasis
Farahmandian et al. PRELIMINARY TRIAL ON THE EFFECT OF LEAVO-TETRAMISOLE ON VARIOUS INTESTINAL HELMINTHIASES IN IRAN
HWANG et al. Therapeutic effect of recurrent corneal erosion by Nd: YAG anterior stromal puncture

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20101018